IBDEI143 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19616,1,4,0)
 ;;=4^682.6
 ;;^UTILITY(U,$J,358.3,19616,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,19616,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,19617,0)
 ;;=682.1^^105^1233^9
 ;;^UTILITY(U,$J,358.3,19617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19617,1,4,0)
 ;;=4^682.1
 ;;^UTILITY(U,$J,358.3,19617,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,19617,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,19618,0)
 ;;=376.01^^105^1233^10
 ;;^UTILITY(U,$J,358.3,19618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19618,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,19618,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,19618,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,19619,0)
 ;;=681.10^^105^1233^11
 ;;^UTILITY(U,$J,358.3,19619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19619,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,19619,1,5,0)
 ;;=5^Cellulitis Of Toe
 ;;^UTILITY(U,$J,358.3,19619,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,19620,0)
 ;;=682.2^^105^1233^12
 ;;^UTILITY(U,$J,358.3,19620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19620,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,19620,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,19620,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,19621,0)
 ;;=070.1^^105^1233^26
 ;;^UTILITY(U,$J,358.3,19621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19621,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,19621,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,19621,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,19622,0)
 ;;=070.30^^105^1233^27
 ;;^UTILITY(U,$J,358.3,19622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19622,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,19622,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,19622,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,19623,0)
 ;;=070.32^^105^1233^28
 ;;^UTILITY(U,$J,358.3,19623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19623,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,19623,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,19623,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,19624,0)
 ;;=070.51^^105^1233^29
 ;;^UTILITY(U,$J,358.3,19624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19624,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,19624,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,19624,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,19625,0)
 ;;=070.54^^105^1233^30
 ;;^UTILITY(U,$J,358.3,19625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19625,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,19625,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,19625,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,19626,0)
 ;;=571.41^^105^1233^32
 ;;^UTILITY(U,$J,358.3,19626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19626,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,19626,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,19626,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,19627,0)
 ;;=571.1^^105^1233^33
 ;;^UTILITY(U,$J,358.3,19627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19627,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,19627,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,19627,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,19628,0)
 ;;=070.59^^105^1233^34
 ;;^UTILITY(U,$J,358.3,19628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19628,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,19628,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,19628,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,19629,0)
 ;;=V08.^^105^1233^24
 ;;^UTILITY(U,$J,358.3,19629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19629,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,19629,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,19629,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;
 ;;$END ROU IBDEI143
